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0 ver the past decade, the number of clinical trials registered with the Food and Drug Administra- tion (FDA) has increased dramatically.’ The 
business of clinical research has become more diverse, in- 
volving academic institutions, clinician-researchers in 
community settings, pharmaceutical companies, and con- 
tract research organizations. This growth has been 
accompanied by increasing concerns about the ethical con- 
duct of research.2 Much of this concern has been directed to 
procedural issues including institutional review board (IRB) 
review, data monitoring, and informed consent forms. How- 
ever, the protection of human subjects cannot be achieved by 
relying solely on procedural safeguards. There are more nu- 
anced issues related to recruitment and retention of subjects, 
and to the process of informed consent: that are generated 
during the interaction between study staff and subjects. It is 
only through an examination of these relationships4 that one 
can more fully define and understand the challenges of pro- 
tecting subjects in research. 
Study coordinators are at the center of the clinical re- 
search enterprise. In collaboration with principal investigators, 
they assist with protocol development, write consent forms, 
recruit subjects, explain the study to and obtain consent from 
subjects, coordinate with relevant hospitalklinic units, col- 
lect and maintain clinical data, and serve as the main contact 
person for subjects during a trial. One recent survey identi- 
fied 128 different activities performed by study coordinators? 
Studies have shown that adding a coordinator to a research 
team significantly improves subject recruitment numbers,6 en- 
hances subject retention,’ and increasesgeneral study effiaenq? 
Much of study coordinators’ added efficiency is a result 
of their central position in clinical research activities. They 
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see themselves as interpreters or liaisons, especially in their 
relationships with principal investigators and subjects, rep- 
resenting the study to subjects and subjects to fellow 
researchers, clinical staff, and to relevant institutional and 
external (e.g., federal government, financial sponsor) ac- 
tors. Each relationship may require a different role, but more 
commonly, the study coordinator position requires that one 
relationship encompass several roles. Of particular interest 
is how clinical study coordinators reconcile the roles of 
caregiver and researcher. Some reports focus on study coor- 
dinators’ successful combination of these two roles: while 
others emphasize their inherent incompatibility.10 
Despite literature that chronicles their skills and effi- 
ciencies, surprisingly little systematic information is available 
regarding the impact of the study coordinator on the protec- 
tion of human subjects. In fact, when study coordinators have 
been in the limelight, it has often been as objects of rebuke. 
For example, approximately 19 percent of investigators re- 
ceiving FDA warning letters in 2000, and more than 37 
percent in 2001, were cited for failing to supervise their 
trials.’ ’ In an anecdotal analysis of twenty of these incidents, 
almost half of the investigators blamed study coordinators 
for their citations.12 
STUDY COORDINATORS ANDTHE ETHICAL Comua OF 
RESEARM 
Given this ambiguous profile, a key question to answer is 
the extent to which study coordinators shape the ethical con- 
duct of clinical research and how their multiple roles affect 
the protection of subjects. To understand these issues, we 
conducted interviews with study coordinators, asking them 
to respond to scenarios that presented a series of potential 
dilemmas. We recruited participants from three types of work 
settings - an academic medical center, a federal research 
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“(T)he research process and the nursing 
process are very similar. The researcher, like 
the nurse, assesses and reassesses needs, 
develops and implements plans, and gathers 
data to promote better patient care.” * 
“Research, irrespective of the methodology adopted, 
calls for an entirely different set of core values from 
those demanded of nursing, requiring detachment 
rather than caring concern, objectivity rather than 
subjectivity, hard nosed analysis rather than intuition, 
pro-activity rather reactivity. Consequently, directives 
to conduct research may implicitly be directives to 
relinquish the essential characteristics of nursing.”** 
I 
*D.A. Seguin, “My Role as a Research Nurse Coordinator,” Critical Care Nursing. 12 (1990): 39-44, at 43. **C. Hicks, “Nurse- 
Researcher: A Study of a Contradiction in Terms?,” Journal of Advanced Nursing, 24 (1996): 357-63, at 358. 
institution, and private organizations. Our underlying hy- 
pothesis was that a variety of orientations toward patient 
care and clinical research might engender different responses. 
Focus group interview study 
The study was approved by the IRBs at the University of 
North Carolina School of Medicine (UNC) and the National 
Human Genome Research Institute. Informed consent was 
obtained from all focus group participants. Pilot interviews 
with thirteen study coordinators at UNC identified key is- 
sues. Because these issues proved potentially complex and 
contingent, we selected focus group discussions, designed to 
foster conversation about specific topics among people with 
similar backgrounds, as our method of data collection. The 
ability to assess participants’ reactions to statements by peers, 
as well as the type of language and phrasing used, give focus 
groups their special purchase on social intera~ti0n.l~ To ac- 
commodate potential sensitivity about our questions, an issue 
raised in pilot interviews, we selected a vignette-based ap- 
proach, a projective teshnique that allows respondents to discuss 
issues without direct personal  reference^.'^ The design of 
these focus groups was more structured than is usually the 
case,Is 
The first set of vignettes elicited information about study 
coordinator skills and roles. The groups were presented with 
h ~ o  different job advertisements with three potential candi- 
dates for each, and were asked to decide who would be the 
best for the job. Participants also commented on contrasting 
statements about the compatibility of nursing with clinical 
research (see Box 1). 
The second set of vignettes posed questions about two 
hypothetical study coordinators recruiting subjects for a hy- 
pertension outpatient study and an oncology trial for patients 
whose disease had failed to respond to conventional thera- 
pies. The moderator led the group through a series of questions 
about the following topics: (1) appraisal of subject motives; 
(2)  recruitment methods; (3) responses to subjects’ hope for 
direct medical benefit in a trial: (4) responses to subjects’ 
desire to withdraw from a study; (5) pressure from investiga- 
tors and study sponsors to increase enrollment numbers; and 
(6) difficulties involving other staff in recruitment and sub- 
ject follow-up (see Table 1). 
In 2000, we conducted seven 90-minute focus groups: 
three at the UNC, a public academic medical center with a 
mix of patient care and clinical research; two at the Warren 
G. Magnuson Clinical Center (NIH), a government organi- 
zation dedicated to research; and two private focus groups 
with participants from the Research Triangle Park area of 
North Carolina and the Washington, D.C. area. These pri- 
vate sector participants worked as freelance consultants or as 
employees of research foundations, private research insti- 
tutes, and contract research organizations; one private sector 
participant was employed full time by the research arm of a 
private clinic. There was a total of forty-five participants; 68 
percent had nursing backgrounds. Other backgrounds in- 
cluded social work, genetic counseling, general baccalaureate, 
and public health, with education levels also varying from 
high school to doctoral degrees (see Table 2). 
Informed consent was obtained from all participants. 
Discussions were audio-taped and transcribed. Analysis of 
the transcripts led to a codebook of twelve index codes (see 
Table 3), each with dozens of subcodes produced through an 
iterative process that involved several readings of the text 
and revisions of the codes. Each of the investigators was 
involved in code development and validation, with three of 
us (Davis, Hull, and Henderson) coding and reconciling the 
seven transcripts in teams of two, and bringing disagreements 
back to the larger group. Transcripts were coded using a 
qualitative analysis program, NUD.IST version 5.16 
Analysis of the focus groups suggests that study coordi- 
nators have a central position, with complex relationships, 
role expectations, and the potential for conflict among the 
roles. 
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Job #1: Federally funded 
multicenter melanoma study, 
with fifty inpatient subjects, 
followed for 5 years care 
.Registered nurse, with 6 years experience in adult critical care nursing, 
coordinator experience in cardiology 
.Pharmacist, masters level, with 15 years hospital experience, 6 years in cancer 
.Social worker, masters level, with 3 years experience in oncology and bone 
marrow transplantation 
Job #2: Industry hnded 
asthma study, with 80 subjects, 
comparing inhaler regimens over 
.Respiratory therapist in university asthma unit, experience in asthma education 
.Clinical nurse specialist, masters level, specialist in asthma clinic, prior 
experience with chronic obstructive pulmonary disease and cystic fibrosis 
Study #1: Phase I1 outpatient 
study, recruitment comparing 
two medications for hypertension 
.How to recruit two clinic patients (new vs. current patient)? 
.What aspects of study or subjects influence recruitment? 
.What do subjects look for in this kind of study? 
.When a subject expresses hope, what does SC say? 
.What happens if others (clinic staff) aid in recruitment efforts? 
.Principal Investigator worries about enrollment, but subject wants to withdraw? 
.What if sponsor offers cash incentive to increase enrollment? 
.What other incentives are important to SCs? 
Study #2: Phase I study of 
treatment for patients whose 
lung cancer failed to respond to 
standard therapy 
.How to recruit two clinic patients (new vs. long time patient)? 
.What aspects of study or subjects influence recruitment? 
.What do subjects look for in this kind of study? 
.If SC knew subject in another trial, would that matter? 
.When a subject expresses hope, what does SC say? 
Number of Groups 





Mean Total Years as SC 
Range of Years as SC 
Highest Degree: High School 
2-Year Nursing 
3-Year Nursing 
BS in Nursing 
Other BNBS 
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1. SC Professional Background 
2. Types of SC skills 
3. SC jobhole characteristics 
4. Research subject characteristics 
5. Study characteristics 
6. Subjects’ motivation to enroll in study 
7. SC recruitment approaches/strategies 
8. SC retention strategies and issues 
9. SC motivation to do recruitmentljob 
10. Prior and current relationships 
1 1. Challenges faced by SC 
12. Areas self-identified by SC where education 
is needed 
Unless otherwise noted, all quoted material in this ar- 
ticle is attributable to study coordinators who participated in 
our study. 
THE STUDY COORDINATOR P S ~ O N  IN CLINICAL 
RESEARCH 
Multiple skills and relationships 
The study coordinator position requires a wide variety of 
skills, including nineteen general skill types, and twenty-five 
subcategories (see Table 4). Most frequently mentioned were: 
hands-on clinical skills; the ability to advance research goals 
using a variety of research-related skills; psychosocial skills; 
communication skills; and complex organizational skills in- 
cluding managing the protocol, functioning as a team 
member, and coordinating with outside units. Intrinsic to 
several of these skill sets is the study coordinator’s ability to 
identify necessary relationships with others, inside and out- 
side the research team, and to forge and sustain them. A 
number of different relationships were identified; the most 
frequently cited relationships were with supervisors, includ- 
ing principal investigators, and patient-subjects (see Figure 1). 
Patient care background 
For some, nursing and research are “a wonderful match . . . 
because you really get to utilize your nursing background.” 
In our job application vignettes, the nursing candidates were 
most often selected because their hands-on skills, clinical 
expertise, and psychosocial skills were identified as excellent 
preparation for the job. If not trained as nurses, coordinators 
need to be patient-oriented. As one participant noted, “If 
you’re going to be dealing with patients at all, you can’t totally 
1. Prior clinical experience 
2. Prior research experience 
3. Technicalhands-on clinical skills 
4. Clinical research skills 
5. Teaching skills 
6. Psychosocial assessment and counseling skills 
7. Organizational/planning/management skills 
8. Communication (with public, others, etc.) 
9. Ability to balance competing issues 
10. Identification of “ethical” problems 
1 1. Patient advocacy skills 
12. Subject protectiodadvocacy skills 
13. Ability to advance research goals 
14. Honesty 
15. Objectivity (non-biased) 
16. Detachment 
17. Creative problem solving 
18.“Multifaceted preparation” 
19. Respect for people (includes sensitivity/patience) 
FIGURE 1. STUDY COORDINATOR’S (SC) CENTR~L.  
POSlTION: 
SubjecVFamilies 
ClinicsDepartments I IRBs 
Other Supervisors -x  Referral Networks 
Study Staff Study Monitors 
Principal Investigator 
disassociateyoursehreswith [sic] what a nurse needs [to know], 
because at some point you’re going to leave the page and talk 
with a human.” In contrast, a nursing background can be 
seen as detrimental when it interferes with the research 
agenda. A private sector group noted that many nurse study 
coordinators have problems with protocols that deviate 
from the standard of care. As one participant in the group said, 
“I have great nurses working for me and [sometimes] I could 
pull my hair out because I can’t get them in the research mode.” 
THETHREEADVOCACIES 
As one of the participans noted, “One criterion for a study 
coordinator is . . . the ability to balance all of the issues from 
the clinical trial side and the medical patient care side, and 
translate both to the principal investigator, who mostly is 
medically-oriented, and to the patient involved in the study.” 
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Before, during, andor 
is as a patient advocate, and I 
don't think you divorce yourself 
from that because you are doing 
some kind of research related to 
a particular hypothesis. And if 
you are, then you should not do 
research. I don't think." 
Rights and welfare of individual 
as research subject 
Before and/or during a study 
"lawyer" 
"I always approach people, even 
people I know well, from that 
sort of objective point of view 
and kind of try to work with 
them, giving them all the facts 
and then let them collaborate 
with us. See what they think they 
can tolerate and that might be 
best for them. So I feel you can 
offer this to somebody that you 
know well and that's been 
through it, but just being as clear, 
crystal clear that you are not 
trying to seduce them into it, that 
there are good and bad points to 
being in a study." 
hies to be hope-neutral, 
iroviding accurate information 
'or decision making 
iies to be hope-neutral, focusing 
a voluntariness, no promise of 
lenefit, and minimized risk 
Focus group participants consistently described their position 
in terms of complex and potentially conflicting obligations 
to various parties. They identified three critical roles: (1) 
patient advocacy; (2) subject advocacy; and (3) study advo- 
cacy (see Table 5 ) .  One role is often identified in contrast 
with another. Participants discussed the moral dimensions of 
these conflicts. Their discussions focused on relationships; 
only occasionally did they explicitly describe conflicts as 
ethical issues. 
Patient advocacy 
All focus group participants identified patient advocacy as 
their primary responsibility. Contrasting this with the inves- 
Advancing research goals; 
gathering valid, clean data via 
good recruitment and retention of 
subjects 
Study specific 
"policeman of protocol" 
"teacher" 
"Once you make the decision that 
you like this protocol, you think 
there's some value here, you think 
it's something you want to do, 
then you have a commitment to 
the protocol, and you shouldn't 
have conflicts .... You need to be 
in a position to defend it honestly 
and comfortably." 
Recognizes that hope may 
encourage participation 
Hopes that the study will be 
successful or that altruism will 
benefit the subject 
tigator role, one participant noted: "You're still the patient 
advocate. You know, you have to think about what your pri- 
ority is. Enrollment, I think, is the [principal investigator's] 
priority, but that's not necessarily your priority." Study co- 
ordinators often think in terms of a patient's interests and 
needs. This commitment to the patient's welfare translates 
into an advocacy for the patient that follows the subject into 
the study," and remains a central role for the study coordina- 
tor during the study and perhaps thereafter. The salience of 
the patient advocate role may affect which patients the study 
coordinator talks to about the study, and whether the study 
coordinator encourages or discourages interest in participat- 
ing. Another participant noted that the study coordinator has 
to be very careful because the patients "look to you as an 
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advocate for them . . . . They [easily conclude that] you’re 
recommending [what they should do].” Patient advocacy was 
reflected in the participants’ explicit use of the term “patient 
advocate” as a metaphor, and in comments about “mother- 
ing” or “taking care of ’’ patients. 
Subject advocacy 
Study coordinators are vital to the investigator’s ability to 
enroll and retain subjects. The role as subject advocate 
emerged in descriptions of the recruitment process, though 
study coordinators typically continue to use patient rather 
than subject terminology. Subject advocacy promotes an in- 
formed decision to participate in research: it entails the 
subject gaining an understanding of the study7s purpose, of 
the nature of voluntary consent and the corresponding ability 
to withdraw from the study, and that declining to participate 
will not affect their current health care in that setting. One 
participant summed up a common description of the role, in 
terms of risk and subject safety: “I think that the subject, if 
the coordinator is doing the job as it should be done, sees 
the coordinator as an advocate, understands . . . that there are 
risks, but that the coordinator is there to be tuned in to 
anything that might, you know, indicate that something is 
going on that might be harmful to the subject.” Although 
investigators may certainly advocate for subjects, coordina- 
tors contrasted their role with the investigator’s role, including 
access to information that investigators do not have: “You’re 
the one listening and dealing with the patient.. .. They’re not 
there.” For subject advocacy, the metaphor used by study 
coordinators was “lawyer,” to protect the rights of this indi- 
vidual and to remind investigators of the subject’s right to 
withdraw from the study. Subject advocacy does not sur- 
vive the end of participation in the study, but the relationships 
acquired may be satisfying personally, or may be instrumen- 
tal in future recruitments. 
Study advocacy 
Study coordinators are hired to advocate for the study. Par- 
ticipants discussed study advocacy in terms of advancing the 
research goals, and gathering valid clean data via good re- 
cruitment and retention of subjects. They also emphasized 
responsibilities of the enrolled participants: “It’s important 
for subjects to also understand that [commitment].” Beyond 
that, study coordinators expressed a need to believe in the 
value of a study. Without that, the job is more difficult, even 
undesirable. Advancing the study may also advance the in- 
vestigator and study coordinator’s professional careers. 
Therefore, there are personal stakes, as well as scientific 
outcomes. The metaphor used here was “policeman of the 
protocol,” and also “teacher,” because often the study coor- 
dinator trained others, including other staff members, in the 
conduct of the study. Study advocacy does not survive the 
conduct of the study, but good performance can be profes- 
sionally advantageous. 
BALANCINGTHEROLES 
Because the three advocacies have different objectives, they 
must be balanced. Although there are instances when the 
advocacies are synergistic, the more common result of bal- 
ancing is one of potential conflict. One advocacy may hinder 
the advancement of another. For example, when a coordina- 
tor carefully maintains an objective stance as astr@ect advocate, 
this may conflict with the role of patient advocate, advising 
patients who are dependent on the study coordinator for guid- 
ance. Likewise, patient advocacy can be burdensome in the 
course of study advocacy, as described by one participant: “It 
is very, very important to be very objective, so patients un- 
derstand that if they do enroll in a study, we’re not saying 
that this is going to fix you or cure you. This is research and 
we’re learning from it, you know. We’ll do everything to 
make sure that you’re safe . . . and [we will stop] if we need 
to, but I think that’s where [I get into] conflicts because pa- 
tients are just so hopeful.. .. You want patients to be positive, 
but you need to be realistic too.” 
Balancing can be difficult. As noted by one participant: 
“It takes a while to develop a balance so that you can be the 
patient advocate but you can also be the researcher, and when 
you have to be tough, and when you have to say to the doctor 
that they’ve had enough.. .. A lot of it is experience.” And 
this balancing is necessary throughout the course of a study. 
As early as protocol development, where the study coordina- 
tor assists the investigator in creating a study design reasonable 
for its subjects, and during the study’s implementation, via 
recruitment, screening, and enrollment, the study coordina- 
tor balances concerns for the patient, the subject, and the 
study. After enrollment, the balancing of advocacies contin- 
ues as the study coordinator addresses data collection and 
retention issues such as compliance, managing side-effects, 
and withdrawals. 
We examined how study coordinators balanced their 
multiple roles in two ways - from a general question about 
the care giving and researcher roles, and a specific question 
in the cancer trial vignette about how one should respond to 
a hopeful patient subject. When the participants considered 
the contrasting quotes from the literature (see Box l), they 
provoked a discussion about the general compatibility of 
nursing and clinical research. Participants argued that the 
study coordinator position must include both the curing com- 
ponent of nursing and the detached analytical gathering of 
knowledge that is fundamental to research. ‘“you have to be 
clear] that you’re doing research and there’s a point to it and 
its not clinical care, but it includes [clinical care]. It includes 
. . . being empathetic and education and all the things nurses 
do in a clinical setting. However, there’s a specific point and 
you have to be somewhat ... rigid to get that objective.” 
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Response to the hopeful patient subject vignette illus- 
trated more particularized relationships and skills. The need 
for “balancing hope and realism,” was consistently identified 
as the “tough part of the job.” These study coordinators 
struggled with their perception that they must be realistic 
with patients, an aspect of all three advocacies, but without 
destroying the therapeutic value of patients’ hope, a main- 
stay of patient advocacy. They worried about not misleading 
patients who could “easily get the wrong impression,” since 
“just being referred gives them hope.” “When patients are 
willing to try anything,” study coordinators say they have to 
protect patients from themselves, and this “makes it kind of 
hard on the coordinator.” Responding to the hopeful subject, 
as patient advocates, they want to encourage patients’ hope 
but not take advantage of it. As study advocates, they recog- 
nize the value of hope in encouraging subject participation; 
and as subject advocates, they move away from both of those 
positions to one of neutrality, providing information but with- 
out unduly influencing decision-making. 
The picture would be incomplete without recognizing 
the parallel tension between hope and realism in members 
of the research team as well. As patient advocates, study 
coordinators themselves hope that the patient win benefit 
from participation in a specific study, or at least will benefit 
from better care while “on study.” Coordinators’ “belief in a 
study,” as study advocates, evinces their hope that the study 
will work, or that altruism is beneficial for patients. Re- 
searchers’ hopefulness in individual benefit and in the 
successful outcome of the study is tempered by subject advo- 
cacy with its “hope neutral” realistic focus on key features of 
research participation: that patients choose to participate for 
their own reasons, that benefit is not promised, and that 
subject safety measures are in place. 
Influence of workplace setting on balan’cing roles 
We found surprisingly little variation in description of the 
study coordinator role across the three different work set- 
tings. There were, however, some differences in degree of 
emphasis on one advocacy versus another. For instance, when 
describing the challenge of balancing hope versus realism for 
hopeful subjects, the UNC study coordinators emphasized 
patient advocacy. The NIH coordinators focused on both 
subject and study advocacy, such as patient safety and dose- 
tolerance; while the private sector sites emphasized good 
study results. Private sector participants further advised keep- 
ing a certain distance from subjects’ hopefulness, to listen 
and “then go on your way.” Perhaps not surprisingly, study 
advocacy appeared to be more fully articulated in the NIH 
and private sectors, settings that are research-oriented and 
have a more clearly defined study coordinator role, hierar- 
chy, and support system. 
THE h s m u  HAND IN CLINICAL RESEARCH 
Focus group participants across all settings described them- 
selves as advocating for patients, patients-turned-subjects, and 
research. While not representative of all study coordinators 
or research organizations in general, the finding of similar 
roles across carefully selected case comparisons such as these 
-when differences are expected by design-is compelling.’* 
Previous literature about study coordinators has ac- 
knowledged the tension between the dual role of researcher 
and ~aregiver.‘~ Our results suggest that, in fact, study coor- 
dinators have several roles, and more importantly, that these 
roles must be balanced. Balancing the three roles heightens 
the potential for conflict as the study coordinator promotes 
the interests of each part of the triad: the patient, the pa- 
tient-turned-subject, and the study. Clearly, there are times 
when one advocacy must advance and the others retreat, 
and deciding which one to focus upon and which ones to 
subrogate is the major ethical challenge of the study coordi- 
nator position. 
The constant movement between different roles, coupled 
with the potential for influential long-term relationships, also 
increases the complexity of the position and reinforces its 
centrality. Coordinator is often noted to be the best descrip- 
tor of the job, following a string of labels denoting tasks that 
range across different relationships and skills, from study 
conception to follow-up.2o While recent literature has also 
focused on the efficiencies of the position,l’ study coordina- 
tors still tend to be invisible players in much of the general 
clinical research and ethics literature. 
Why have study coordinators been neglected in the lit- 
erature on the protection of subjects in research studies? One 
answer is that the job has been considered an assistant’s po- 
sition, with little authority or autonomy. A profession is often 
defined by a group’s ability to control the application of a 
body of knowledge and establish training programs that award 
jurisdiction over that knowledge to recipients.22 In contrast, 
the study coordinator is an occupation in transition, lacking 
agreed upon training requirements or job criteria. Neither 
the creation of the research nurse ~ubspecialty;~ or the estab- 
lishment of a clinical research coordinator certification 
program by the Association of Clinical Research Profession- 
als (ACW), has resulted in an independent professional 
identit); for study coordinators. New National Institutes of 
Health guidelines do require all “key personnel” involved 
in research to certify receipt of ethics trainingz4 With the 
rapid proliferation of excellent clinical research training 
courses, the focus is on the investigator; there is no certainty 
that study coordinators will be included as key personnel 
and therefore required to receive training in ethical issues 
related to human subjects protection. 
In fact, the challenges we describe that are raised by 
study coordinators’ different advocacies resonate with much 
that has been written about the dual role faced by physician- 
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 investigator^.^^ While our purpose was not to examine the 
similarities of these two roles, the fact that the potential role 
conflicts seem S i a r  only serves to reinforce the importance of 
the study coordmator role for the protection of human subjects. 
Moreover, because of their central position and their 
commitment to balancing the three advocacies, study coor- 
dinators are uniquely placed to further the goals of human 
subject protection. The study coordinator is the person with 
whom subjects interact the most, and the one most able to 
identify their needs and employ necessary procedural safe- 
guards. Often, challenges that raise ethical issues are most 
apparent to study coordinators, yet their particular perspec- 
tive may go unnoticed or  be misunderstood. Such 
misunderstanding may be cast as blame for ethical lapses in 
the study, an age-old issue for study coordinators starting 
with Nurse Rivers, a “scientific assistant” in the Tuskegee 
syphilis and persisting today in commentary about 
FDA warning letters, as described in the introducti~n.~’ 
The findings that study coordinators face challenging 
issues related to human subjects protection demonstrate why 
it is critical that study coordinators be included in research 
ethics training programs. Indeed, the focus group discussions 
revealed participants’ keen interest in research ethics educa- 
tion, and in a forum to discuss their ethical issues. These results 
also suggest that evaluating the adequacy or inadequacy of 
the protection of human subjects cannot rely solely upon 
procedural safeguards such as IRB review, data monitoring, 
or informed consent forms. It must include explicit recogni- 
tion of the study coordinator’s role. Further research to test 
our findings regarding the role of study coordinators in recruit- 
ment, consent, and retention is also indicated. Through greater 
recognition of the invisible hand in clinical research, we can 
better address the complex issues of human subjects protection. 
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